Industry User Meetings

Industry User Meetings are open to all attendees. Registration links (if applicable) will be added to this page in the coming weeks. Links to the actual event will be added to this page and to the Networking Room in the meeting platform prior to the start of the event. Please visit the companies in the Virtual Exhibit Hall for further information on these exciting events.  

Saturday, June 12

9:15–10:15 am ET

A Case-Based Discussion of Detectnet™ (copper Cu 64 dotatate injection) 
Andreas Kjaer, MD, PhD (University of Copenhagen, Nuclear Medicine Specialist)

The presentation will focus on clinical data, including results from head-to-head European studies and the US pivotal Phase III trial. The discussion will conclude with several in-depth reviews of recent patient cases with Detectnet and an opportunity for Q&A.

Sunday, June 13

7:45-9:45 pm ET

The Journey to Approval of a Commercially Available 18F-PSMA PET/CT Imaging Agent for Prostate Cancer 


7:45-8:45 pm ET

360º CZT Transformative Innovation
Addressing the challenges of 2D Nuclear Medicine
VERITON-CT Digital SPECT/CT: 3D Imaging and Beyond


Monday, June 14

8:45–9:45 am ET



8:45–9:45 am ET



8:45–9:45 am ET

Practical Applications of USP <825>
Lisa Koss, RPh, BCNP and  Jeanine Halverson, RPh  
Register for this user meeting.

US Pharmacopeia (USP) published Chapter 825 and made the guidelines final as of Dec, 31, 2020. This presentation will discuss the history, components and risk levels of USP <825>.  The USP Chapter <825> guidelines for commercial nuclear pharmacies will be presented with practical application approach and details of the changes affecting nuclear medicine departments will be discussed. You will learn how to apply USP <825> standards to your daily radiopharmacy practice. A Q & A panel discussion will follow the presentation.

Objectives:

  • Discuss USP Chapter <825> and history
  • Components and risk levels of USP <825>
  • USP Chapter <825> Requirements for commercial nuclear pharmacies
  • Changes affecting nuclear medicine departments 
  • Applying USP <825> standards to your daily practice

This activity is worth 1.00 CEHs (Continuing Education Hours).

8:45–9:45 am ET

   MIM Software SNMMI 2021 User Meeting
 
Speaker:
James Patrick Buteau, MD Nuclear Medicine, Department of Medical Imaging Hôpital Cité de la Santé de Laval, Peter MacCallum Cancer Centre

Nuclear Medicine is evolving, and new opportunities are on the horizon. How are you planning to adapt?
Join MIM Software’s user meeting during the 2021 SNMMI Virtual Annual Meeting to discover the latest advancements in the field.
Our panel of speakers will discuss radiopharmaceutical therapy developments, PET quantitation and its impact in the clinic today and in the future, new PET tracer support, and more.
 

7:45–8:45 pm ET

The uMI User Experience

The discussion of the real-world implementation of the ultra-resolution digital PET/CT from clinical to business perspective.


Tuesday, June 15

8:45–9:45 am ET

 Ultimate tools for research in molecular imaging: introduction of the AnyScan TRIO SPECT/CT

In the presentations we will introduce the AnyScan TRIO SPECT/CT, the only triple-detector SPECT/CT for high-end clinical research applications with both parallel hole and multi-pinhole collimation. We will provide an overview of the nanoScan preclinical molecular imaging platform focusing on new features and developments. Finally, our users will report on their experience using both preclinical (nanoScan) and clinical (AnyScan TRIO) research systems.